IFF - International Flavors & Fragrances Inc Stock Analysis
International Flavors & Fragrances Inc (IFF) is a publicly traded company listed on the NYSE. It operates in the Specialty Chemicals industry, part of the broader Basic Materials sector. The company has a market capitalization of 17.03B, generates annual revenue of 11.07B, and reports net income of -412.00M. As of the latest data, the stock is trading at 66.49 USD.
From a valuation and risk perspective, the stock presents the following profile: The P/E ratio is unavailable or not meaningful at this time. The PEG ratio is below 1, which may indicate the stock is undervalued relative to its growth potential. The company maintains a healthy balance between debt and equity, which is typical for stable businesses. The stock offers a moderate dividend yield (2.4%), which may appeal to income-focused investors. The stock has average market volatility, aligning with general market movement.
Analyst recommendation stands at Hold (3.92), indicating current market sentiment. Institutional ownership is reported at 95.82%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of -27.15%, trading within a 52-week range of 59.14 - 90.64.
IFF - International Flavors & Fragrances Inc
66.49
Analyst Consensus
Hold 3.92
IFF – Analyst Rating Summary
- Strong Buy: 6
- Buy: 12
- Hold: 6
- Sell: 1
- Strong Sell: 0
- Total Analysts: 25
| Index: | S&P 500 | P/E: | - | EPS (ttm): | -1.62 | Insider Own: | 2.00% | Shs Outstand: | 256.30M | Perf Week: | -4.71% |
| Market Cap: | 17.03B | Forward P/E: | 14.80 | EPS next Y: | 4.49 | Insider Trans: | 0.60% | Shs Float: | 250.99M | Perf Month: | 8.13% |
| Income(ttm): | -412.00M | PEG: | - | EPS next Q: | 0.83 | Inst Own: | 95.82% | Short Float: | 2.51% | Perf Quarter: | 0.70% |
| Revenue(ttm): | 11.07B | P/S: | 1.54 | EPS this Y: | -1.25% | Inst Trans: | 1.19% | Short Ratio: | 2.71 | Perf Half Y: | -13.04% |
| Book/sh: | 55.56 | P/B: | 1.20 | EPS next Y: | 5.55% | ROA: | -1.48% | Short Interest: | 6.30M | Perf Year: | -27.15% |
| Cash/sh: | 2.42 | P/C: | 27.42 | EPS next 5Y: | 4.38% | ROE: | -2.84% | 52W Range: | 59.14 - 90.64 | Perf YTD: | -21.36% |
| Dividend Est.: | 1.60 (2.40%) | P/FCF: | 51.29 | EPS past 3/5Y: | -4.88% -24.99% | ROIC: | -2.11% | 52W High: | 90.64 -26.64% | Beta: | 1.06 |
| Dividend TTM: | 1.60 (2.41%) | Quick Ratio: | 0.86 | Sales past 3/5Y: | -0.49% 17.44% | Gross Margin: | 31.15% | 52W Low: | 59.14 12.43% | Perf 5Y: | -41.09% |
| Dividend Ex-Date: | Dec 19, 2025 | Current Ratio: | 1.44 | EPS Y/Y TTM: | 82.30% | Oper. Margin: | 9.85% | RSI (14): | 51.28 | Volatility: | 2.03% 2.72% |
| Employees: | 22400 | Debt/Eq: | 0.47 | Sales Y/Y TTM: | -3.01% | Profit Margin: | -3.72% | Recom: | 1.82 | Target Price: | 79.69 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.37 | EPS Q/Q: | -32.23% | Payout: | 168.56% | Rel Volume: | 0.78 | Prev Close: | 67.12 |
| Sales Surprise: | 2.26% | EPS Surprise: | 3.25% | Sales Q/Q: | -7.90% | Earnings: | Nov 04 AMC | Avg Volume: | 2.32M | Price: | 66.49 |
| SMA20: | 0.19% | SMA50: | 3.82% | SMA200: | -6.82% | Undervalued: 19.85% | Volume: | 1,807,693 | Change: | -0.94% | |
Graham Classic formula value: -25.11
(P/E=8 * 1g) Min value: -18.01
(current P/E * 2g) Max value: -12.74
Average value: -18.62
About International Flavors & Fragrances Inc
International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish segment consists of legacy Taste segment combined with N&B's Food & Beverage division and the food protection business of N&B's Health & Biosciences division. The Health & Biosciences business consists of a biotechnology-driven portfolio of enzymes, food cultures, probiotics and specialty ingredients for food, home and personal care, and health and wellness applications. The Scent business creates fragrance compounds, fragrance ingredients and cosmetic ingredients that are integral elements in the world's finest perfumes and best-known household and personal care products. The Pharma Solutions business produces a vast portfolio including cellulosics and seaweed-based pharma excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling. The company was founded in 1833 and is headquartered in New York, NY.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.